Thank you for visiting PDI Healthcare's US Website.

We notice that you are visiting us from . This site only services US-based visitors. Would you like to visit the site that is appropriate for your location?

*By selecting “yes” we will redirect you to and remember your choice for future visits.

Profend® Nasal Decolonization Kit

Profend Nasal Decolonization Antiseptic kit (4 nasal swabs)

Sani-Cloth® Prime Germicidal Disposable Wipe

Super Sani-Cloth® Germicidal Disposable Wipe

Super Sani-Cloth Germicidal Disposable Wipes (80 wipe container)

Sani-Cloth® Bleach Germicidal Disposable Wipe

Sani-Cloth Bleach Germicidal Disposable Wipes (75 wipe container)

Prevantics® Device Swab & Strip

Prevantics Device Antiseptic Family (100 packets per pack)
/ Product & In-Service Training

« Back to results

Profend® Nasal Decolonization

Type: Video

 

For new hire training or yearly refresher, this in-service video covers a basic product overview and appropriate application of the Profend Nasal Decolonization Kit.

Proactively defend your patients and facility today—choose quick, easy, assured protection of the Profend Nasal Decolonization Kit.

  • Uniquely designed swabsticks pre-saturated with 10% Povidone-Iodine (PVP-I)—just snap and swab.
  • Fast 60-second treatment time.
  • Neat, dry-handle design for limited mess.
  • Small nasal swab for patient comfort.
  • Kills 99.7% of S. aureus at 1 hour and 99.9% at 12 hours.*

 

> View Profend Product Page

 *PDI in vivo Study 0113-CTEVO.

Frequently Asked Questions

  • How is the Profend™ Nasal Decolonization Kit used?

    Show Answer
    The Profend Nasal Decolonization Kit swabsticks are designed to be applied to the circumference of the patient nostril and anterior nares. Two swabsticks are applied to the nostril for 15 seconds per swabstick. Thus, using 4 swabsticks, total treatment time is 60 seconds.

  • What is the Profend™ Nasal Decolonization Kit?

    Show Answer
    The Profend Nasal Decolonization Kit is a pack of four swabsticks that are pre-saturated with 10% (w/w) Povidone-Iodine antiseptic solution and are applied to the nostrils/anterior nares of the nose to proactively defend patients against Staphylococcus aureus (S. aureus), Methicillin-resistant Staphylococcus aureus (MRSA) and other bacteria that can cause Surgical Site Infections (SSIs) and other healthcare-acquired infections (HAIs).

  • When is the Profend™ Nasal Decolonization Kit used?

    Show Answer
    The Profend Nasal Decolonization Kit can be used on patients who have tested positive for S. aureus and/or MRSA. As an alternative to a “test and treat” strategy, the ease and speed of application and economical design make Profend suitable for universal decolonization of all patients, saving time and money spent on patient testing. Regardless of decolonization strategy, Profend has proven efficacy—in a study of healthy volunteers, the Profend Nasal Decolonization Kit reduced S. aureus by 99.7% at 1 hour and 99.9%* at 12 hours post-application.With this in mind, for pre-operative use, clinicians may choose to apply the product to the patient 1-2 hours prior to surgery depending on hospital protocol. SOURCE: PDI in vivo Study 0113-CTEVO.

  • Where is the Profend™ Nasal Decolonization Kit used?

    Show Answer
    The Profend Nasal Decolonization Kit can be used anywhere in a healthcare facility where there are patients who may be nasally colonized with S. aureus or MRSA and therefore have an elevated risk of developing an SSI or other HAIs.

  • Who uses the Profend® Nasal Decolonization Kit?

    Show Answer
    Perioperative nurses who care for patients prior to surgery and nursing staff in other areas of the hospital,ie. ICU, are the primary users of the Profend Nasal Decolonization Kit. Profend offers unique features valued by clinicians – a preference study showed that over 90% of nurses preferred Profend over other PVP-I nasal antiseptic products. SOURCE: PDI user acceptance study.

  • Why is the Profend™ Nasal Decolonization Kit used?

    Show Answer
    Up to 30 percent of adults are nasally colonized with S. aureus and/or MRSA. S. aureus and MRSA account for over 30% of SSIs. Nasal colonization with these bacteria increases the patient risk of developing an SSI by 9 times. To help reduce this risk, Povidone-Iodine is used as it is a broad spectrum antiseptic that has been proven effective in reducing both S. aureus and MRSA. It offers an added advantage over the widely-used nasal antibiotic, mupirocin, in that there is no known bacterial resistance to it, thereby supporting antibiotic stewardship within the healthcare environment.

Follow Us

@

Not recently active